AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has informed the stock exchanges that its trading window will be closed starting March 16, 2026, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will remain shut until 48 hours after the company declares its audited financial results for the fourth quarter and full year ending March 31, 2026. During this period, designated insiders and their immediate relatives are prohibited from buying or selling shares of the company. This is a routine compliance measure taken ahead of the earnings announcement.
This is a standard regulatory disclosure and does not directly impact the stock price. However, it signals that the company's audited Q4 and FY26 results are upcoming, which investors should watch for as it may influence sentiment around the stock.